Suzhou UgeneX Therapeutics Co., Ltd.
Suzhou UgeneX Therapeutics Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Open-Label Trial of UGX202 for Advanced Retinitis Pigmentosa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Not yet recruiting | Phase 1 | 2026-10-02 | NCT07847723 | |
| UGX202 Injection in Patients With Advanced Retinitis Pigmentosa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Not yet recruiting | Early phase 1 | 2025-12-31 | NCT07311863 |